Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garry M Walsh

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Immunotherapy|January 26, 2019
Dupilumab utility in difficult-to-treat asthmaGarry M Walsh
Immunotherapy|March 21, 2018
Reslizumab in the treatment of severe eosinophilic asthma: an updateGarry M Walsh
Current Medicinal Chemistry|November 1, 2006
Targeting airway inflammation: novel therapies for the treatment of asthmaGarry M Walsh
Expert Opinion on Biological Therapy|June 13, 2020
Anti-IL-5 monoclonal antibodies for the treatment of asthma: an updateGarry M Walsh
Expert Review of Respiratory Medicine|May 19, 2010
Statins as emerging treatments for asthma and chronic obstructive pulmonary diseaseGarry M Walsh
Drugs of Today (Barcelona, Spain : 1998)|January 14, 2010
Canakinumab for the treatment of cryopyrin-associated periodic syndromesGarry M Walsh
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 13, 2010
The anti-inflammatory effects of levocetirizine--are they clinically relevant or just an interesting additional effect?Garry M Walsh
The Lancet. Respiratory Medicine|May 15, 2016
Severe eosinophilic asthma and mepolizumabGarry M Walsh
Therapeutics and Clinical Risk Management|May 14, 2008
Editorial forewordGarry M Walsh
Trends in Pharmacological Sciences|December 7, 2007
Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?Garry M Walsh
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Immunotherapy|January 26, 2019
Dupilumab utility in difficult-to-treat asthmaGarry M Walsh
Immunotherapy|March 21, 2018
Reslizumab in the treatment of severe eosinophilic asthma: an updateGarry M Walsh
Current Medicinal Chemistry|November 1, 2006
Targeting airway inflammation: novel therapies for the treatment of asthmaGarry M Walsh
Expert Opinion on Biological Therapy|June 13, 2020
Anti-IL-5 monoclonal antibodies for the treatment of asthma: an updateGarry M Walsh
Expert Review of Respiratory Medicine|May 19, 2010
Statins as emerging treatments for asthma and chronic obstructive pulmonary diseaseGarry M Walsh
Drugs of Today (Barcelona, Spain : 1998)|January 14, 2010
Canakinumab for the treatment of cryopyrin-associated periodic syndromesGarry M Walsh
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|January 13, 2010
The anti-inflammatory effects of levocetirizine--are they clinically relevant or just an interesting additional effect?Garry M Walsh
The Lancet. Respiratory Medicine|May 15, 2016
Severe eosinophilic asthma and mepolizumabGarry M Walsh
Therapeutics and Clinical Risk Management|May 14, 2008
Editorial forewordGarry M Walsh
Trends in Pharmacological Sciences|December 7, 2007
Defective apoptotic cell clearance in asthma and COPD--a new drug target for statins?Garry M Walsh
Pageof 6